Constance John – Founder and CEO
Constance M. John, R.Ph., Ph.D., is the Founder and CEO of MandalMed, Inc. Dr. John holds a B. S. in Pharmacy from the University of Minnesota and a Ph.D. in Pharmaceutical Chemistry from UCSF. In addition to directing MandalMed’s research programs and the unique Bioscience Laboratories incubator that has been located in the SOMA district of San Francisco since 2006, Dr. John is an Associate Professor in the UCSF Department of Laboratory Medicine. Dr. John served as a reviewer in the NIH’s SBIR/STTR program for almost 10 years and has been the PI or co-PI of multiple SBIR awards. Her research experience extends from infectious disease and cancer, to analytical chemistry, spinal cord and traumatic brain injury, and male reproductive biology and toxicology and she has more than 30 peer-reviewed publications. Areas of active interest include prevention of remodeling after myocardial infarction, new strategies to overcome antibiotic resistance, and development of new adjuvants.